MODAFINIL tablet

Ülke: ABD

Dil: İngilizce

Kaynak: NLM (National Library of Medicine)

şimdi satın al

Indir Ürün özellikleri (SPC)
01-06-2023

Aktif bileşen:

MODAFINIL (UNII: R3UK8X3U3D) (MODAFINIL - UNII:R3UK8X3U3D)

Mevcut itibaren:

Proficient Rx LP

Uygulama yolu:

ORAL

Reçete türü:

PRESCRIPTION DRUG

Terapötik endikasyonlar:

Modafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). Limitations of Use In OSA, modafinil tablets are indicated to treat excessive sleepiness and not as treatment for the underlying obstruction. If continuous positive airway pressure (CPAP) is the treatment of choice for a patient, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating and during treatment with modafinil tablets for excessive sleepiness. Modafinil tablets are contraindicated in patients with known hypersensitivity to modafinil or armodafinil or its inactive ingredients [see Warnings and Precautions (5.1, 5.2, 5.3)] . Teratogenic Effects Pregnancy Category C There are no adequate and well-controlled studies of modafinil in pregnant women. Intrauterine growth restriction and spontaneous abortion have been reported in association with mo

Ürün özeti:

Modafinil Tablets USP, 200 mg are white to off-white, capsule-shaped, uncoated tablets, debossed with ‘4’ & ‘2’ separated by score line on one side and ‘J’ on the other side.         Bottles of 30             NDC 71205-544-30         Bottles of 60             NDC 71205-544-60         Bottles of 90             NDC 71205-544-90          Store at 20o to 25o C (68o to 77o F). [See USP Controlled Room Temperature.]

Yetkilendirme durumu:

Abbreviated New Drug Application

Bilgilendirme broşürü

                                MODAFINIL- MODAFINIL TABLET
Proficient Rx LP
----------
MEDICATION GUIDE
Modafinil Tablets, USP CIV
(moe daf' i nil)
Read this Medication Guide before you start taking modafinil tablets
and each time you get a refill. There
may be new information. This information does not take the place of
talking with your doctor about your
medical condition or treatment.
What is the most important information I should know about modafinil
tablets?
Modafinil tablets may cause serious side effects including a serious
rash or a serious allergic reaction that
may affect parts of your body such as your liver or blood cells. Any
of these may need to be treated in a
hospital and may be life-threatening.
Stop taking modafinil tablets and call your doctor right away or get
emergency help if you have any of
these symptoms:
•
skin rash, hives, sores in your mouth, or your skin blisters and peels
•
swelling of your face, eyes, lips, tongue, or throat
•
trouble swallowing or breathing
•
fever, shortness of breath, swelling of the legs, yellowing of the
skin or whites of the eyes, or dark
urine.
If you have a severe rash with modafinil tablets, stopping the
medicine may not keep the rash from
becoming life-threatening or causing you to be permanently disabled or
disfigured.
Modafinil tablets are not approved for use in children for any medical
condition. It is not known if
modafinil tablets are safe or effective in children under 17 years of
age.
What are modafinil tablets?
Modafinil tablets are a prescription medicine used to improve
wakefulness in adults who are very sleepy
due to one of the following diagnosed sleep disorders:
•
narcolepsy
•
obstructive sleep apnea (OSA). Modafinil tablets are used to treat
excessive sleepiness, but not the
obstruction or medical condition that is causing OSA. You should talk
with your doctor about
treatments for OSA before you start taking modafinil tablets and
during treatment with modafinil
tablets. Modafinil tablets do not take the place of treatments that
your doctor has prescribed for
O
                                
                                Belgenin tamamını okuyun
                                
                            

Ürün özellikleri

                                MODAFINIL- MODAFINIL TABLET
PROFICIENT RX LP
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
MODAFINIL TABLETS
SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR MODAFINIL
TABLETS.
MODAFINIL TABLETS, FOR ORAL USE, CIV
INITIAL U.S. APPROVAL: 1998
INDICATIONS AND USAGE
Modafinil tablets are indicated to improve wakefulness in adult
patients with excessive sleepiness
associated with narcolepsy, obstructive sleep apnea (OSA), or shift
work disorder (SWD). (1)
Limitations of Use
In OSA, modafinil tablets are indicated to treat excessive sleepiness
and not as treatment for the
underlying obstruction.
DOSAGE AND ADMINISTRATION
The recommended dosage of modafinil tablets for each indication is as
follows:
•
•
•
•
DOSAGE FORMS AND STRENGTHS
Tablets: 100 mg and 200 mg. (3)
CONTRAINDICATIONS
Modafinil tablets are contraindicated in patients with known
hypersensitivity to modafinil or armodafinil. (4)
WARNINGS AND PRECAUTIONS
•
•
•
•
•
•
ADVERSE REACTIONS
MOST COMMON ADVERSE REACTIONS (≥5%): HEADACHE, NAUSEA, NERVOUSNESS,
RHINITIS, DIARRHEA,
BACK PAIN, ANXIETY, INSOMNIA, DIZZINESS, AND DYSPEPSIA. (6.1) TO
REPORT SUSPECTED
ADVERSE REACTIONS, CONTACT RISING HEALTH, LLC AT 1-833-395-6928 OR FDA
AT 1-800-FDA-
1088 OR WWW.FDA.GOV/MEDWATCH.
DRUG INTERACTIONS
•
•
•
USE IN SPECIFIC POPULATIONS
Pregnancy: Based on animal data, may cause fetal harm. (8.1)
SEE 17 FOR PATIENT COUNSELING INFORMATION AND MEDICATION GUIDE.
REVISED: 6/2023
Narcolepsy or OSA: 200 mg once a day in the morning. (2.1)
SWD: 200 mg once a day, taken approximately one hour prior to start of
the work shift. (2.2)
Severe Hepatic Impairment: reduce dose to half the recommended dose.
(2.3, 12.3)
Geriatric Patients: consider lower dose. (2.4, 12.3)
Serious Rash, including Stevens-Johnson syndrome: Discontinue
modafinil at the first sign of rash,
unless the rash is clearly not drug-related. (5.1)
Angioedema and Anaphylaxis Reactions: If suspected, discontinue
modafin
                                
                                Belgenin tamamını okuyun
                                
                            

Bu ürünle ilgili arama uyarıları

Belge geçmişini görüntüleyin